Table 2 Intra- and postoperative outcomes
Control group n (%) or mean (SD) | Pandemic group n (%) or mean (SD) | p-value | Total | |
|---|---|---|---|---|
Total (n) | 82 (45.1) | 100 (54.9) | 182 (100.0) | |
Early cholecystectomy | 19 (23.2) | 36 (36.0) | 0.061 | 55 (30.2) |
Operation time; min | 94.5 (37.0) | 90.0 (40.2) | 0.266 | 92.0 (38.8) |
IBL; ml | 57.5 (73.9) | 79.2 (124.1) | 0.740 | 69.4 (104.8) |
LOS; days | 4.2 (2.4) | 4.2 (3.0) | 0.337 | 4.2 (2.8) |
Overall morbidity | 10 (12.2) | 8 (8.0) | 0.346 | 18 (9.9) |
Severe complications (Clavien-Dindo > II) | 2 (2.4) | 5 (5.0) | 0.460 | 7 (3.8) |
Surgical revision | 0 (0.0) | 1 (1.0) | 1.000 | 1 (0.5) |
30-day readmission | 1 (1.2) | 2 (2.0) | 1.000 | 3 (1.6) |
30-day mortality | 0 (0.0) | 1 (1.0) | 1.000 | 1 (0.5) |